Palo Alto clinical trial software startup Medable joins unicorns with $304M funding

Medable Inc., a startup whose technology helped to accelerate development of Covid-19 vaccines, nearly tripled its valuation to $2.1 billion in a large venture round announced Tuesday. The nine-year old Palo Alto startup raised $304 million in its fourth funding in the past 18 months, a period in...

Click to view original post